Neuromuscular manifestations of critical illness

Muscle and Nerve

Volumn 32, Issue 2, 2005, Pages 140-163

  Bolton, Charles F ^a  

^a Mayo Clinic   (United States)

Author keywords

Acute quadriplegic myopathy; Critical illness myopathy; Critical illness polyneuropathy; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BN 5202; CREATINE KINASE; IMMUNOGLOBULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM BROMIDE; STEROID; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; VECURONIUM;

ARTIFICIAL VENTILATION; BRAIN DISEASE; CACHEXIA; CREATINE KINASE BLOOD LEVEL; CRITICAL ILLNESS; CRITICAL ILLNESS POLYNEUROPATHY; ELECTROPHYSIOLOGY; HUMAN; INTENSIVE CARE UNIT; MULTIPLE ORGAN FAILURE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOFILAMENT; MYOPATHY; NEUROLOGIC EXAMINATION; NEUROMUSCULAR DISEASE; POLYNEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHABDOMYOLYSIS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT PLANNING;

HUMANS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DISEASES; PERIPHERAL NERVES; POLYNEUROPATHIES; RESPIRATION, ARTIFICIAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 23044456977     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20304     Document Type: Review

References (196)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
2. Butterworths Medical Dictionary. In: Butterworths medical dictionary, 2nd ed. Boston: Butterworths; 1978. p 1415.
3. NHLBI Workshop summary. Respiratory muscle fatigue. Report of the Respiratory Muscle Fatigue Workshop Group. Am Rev Respir Dis 1990;142:474-480.
4. Abd AG, Braun NM, Baskin MI, O'Sullivan MM, Alkaitis DA. Diaphragmatic dysfunction after open heart surgery: treatment with a rocking bed. Ann Intern Med 1989;111:881-886.
5. Aljaberi M, Katirji B. The value of EMG in rhabdomyolysis. Muscle Nerve 1995;18:1043.
6. al-Lozi MT, Pestronk A, Yee WC, Flaris N, Cooper J. Rapidly evolving myopathy with myosin-deficient muscle fibers. Ann Neurol 1994;35:273-279.
7. Amato AA, Barohn RJ, Sahenk Z, Tutschka PJ, Mendell JR. Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology 1993;43:1513-1518.
8. Asbury A. Neuropathies with renal failure, hepatic disorders, chronic respiratory insufficiency, and critical illness. In: Dyck P, Thomas P, editors. Peripheral neuropathy. Philadelphia: WB Saunders; 1993. p 1251-1265.
9. Barat M, Brochet B, Vital C, Mazaux JM, Arne L. Polyneuropathies during prolonged stays in resuscitation. Rev Neurol (Paris) 1987;143:823-831.
10. Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994;17:647-654.
11. Bendahhou S, Cummins TR, Potts JF, Tong J, Agnew WS. Serine-1321- independent regulation of the mu 1 adult skeletal muscle Na+ channel by protein kinase C. Proc Natl Acad Sci USA 1995;92:12003-12007.
12. Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz NJ. Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 1996;22:849-855.
13. Bird SJ. Myopathies and disorders of neuromuscular transmission. In: Brown W, Bolton C, Aminoff M, editors. Neuromuscular function and disease. Philadelphia: WB Saunders; 2002. p 1507-1520.
14. Bird SJ, Rich MM. Critical illness myopathy and polyneuropathy. Curr Neurol Neurosci Rep 2002;2:527-533.
15. Bischoff A, Meier C, Roth F. Gentamicin neurotoxicity (polyneuropathy-encephalopathy). Schweiz Med Wochenschr 1977;107:3-8.
16. Bolton C, Andreychuk J, Voll C. Studies of the cardiac R-R variation and sympathetic skin response in the intensive care unit. Muscle Nerve 1999;22:1318.
17. Bolton C, Brown J, Sibbald W. The electrophysiologic investigation of respiratory paralysis in critically ill patients. Neurology 1983;33:186.
18. Bolton C, Chen R, Wijdicks E, Zifko U. Diseases of the peripheral nervous system. In: Neurology of breathing. Philadelphia: Butterworth-Heineman (Elsevier); 2004. p 165-226.
19. Bolton CF. The changing concepts of Guillain-Barré syndrome. N Engl J Med 1995;333:1415-1417.
20. Bolton CF. Clinical neurophysiology of the respiratory system. Muscle Nerve 1993;16:809-818.
21. Bolton CF. Critical illness polyneuropathy. In: Thomas PK, Asbury A, editors. Peripheral nerve disorders II. Oxford: Butterworth-Heinemann; 1995. p 262-270.
22. Bolton CF. Electrophysiologic studies of critically ill patients. Muscle Nerve 1987;10:129-135.
23. Bolton CF. Evidence of neuromuscular dysfunction in the early stages of the systemic inflammatory response syndrome. Intensive Care Med 2000;26:1179-1180.
24. Bolton CF. Muscle weakness and difficulty in weaning from the ventilator in the critical care unit. Chest 1994;106:1-2.
25. Bolton CF. Neuromuscular complications of sepsis. Intensive Care Med 1993;19:S58-S63.
26. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996;24:1408-1416.
27. Bolton CF. Critical illness polyneuropathy. In: Noseworthy JH, editor. Neurological therapeutics. London: Martin Dunitz; 2003. p. 2229-2236.
28. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984;47:1223-1231.
29. Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1986;49:563-573.
30. Bolton CF, Ramsay DA, Rutledge F. Acute quadriplegic myopathy (AQM), sepsis and the systemic inflammatory response syndrome (SIRS). Neurology 1998;50:242-243.
31. Bolton CF, Young GB. Critical illness polyneuropathy due to parenteral nutrition. Intensive Care Med 1997;23:924-925.
32. Bolton CF, Young GB. Neurological complications of renal disease. Boston: Butterworths; 1990. p 79.
33. Bolton CF, Young GB. The neurological consultation and neurological syndromes in the intensive care unit, neurology: Ballieres Clin Neurol 1996;5:447-475.
34. Bolton CF, Young GB. Sepsis and septic shock: central and peripheral nervous systems. In: Sibbald WJ, Sprung CL, editors. New horizons: perspectives on sepsis and septic shock. Fullerton: Society of Critical Care Medicine; 1986. p 157-171.
35. Bolton CF, Young GB, Zochodne DW. Neurological changes during severe sepsis. Curr Topics Intensive Care 1994;1:759-773.
36. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol 1993;33:94-100.
37. Bone RC. Sepsis syndrome. New insights into its pathogenesis and treatment. Intensive Care World 1992;4:50-59.
38. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002;360:219-223.
39. Campellone JV, Lacomis D, Kramer DJ, Van Cott AC, Giuliani MJ. Acute myopathy after liver transplantation. Neurology 1998;50:46-53.
40. Chen R, Grand'Maison F, Brown JD, Bolton CF. Motor neuron disease presenting as acute respiratory failure: electrophysiological studies. Muscle Nerve 1997;20:517-519.
41. Coakley JH, Nagendran K, Honavar M, Hinds CJ. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 1993;19:323-328.
42. Couturier JC, Robert D, Monier P. Polynervrites compliquant des sejours prolonges en reanimation: a propos de 11 cas d'etiologie encore inconnue. Yon Med 1984;252:247-249.
43. Cowley HC, Heney D, Gearing AJ, Hemingway I, Webster NR. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit Care Med 1994;22:651-657.
44. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14:1131-1139.
45. David WS. Myoglobinuria. Neurol Clin 2000;18:215-243.
46. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002;288:2859-2867.
47. de Letter MA. Critical illness polyneuropathy and myopathy - a neuromuscular disorder encountered in the intensive care unit. Rotterdam: Erasmus Universiteit Rotterdam, 2001.
48. de Letter MA, Schmilz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001;29:2281-2286.
49. De Letter MA, van Doom PA, Savelkoul HF, Laman JD, Schmitz PI, Op de Coul AA, et al. Crilical illness polyneuropalhy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in ihe muscle tissue. J Neuroimmunol 2000;106:206-213.
50. De Saint-Victor JF, Durand G, Le Gulluche Y, Hoffmann JJ. Neuropathies of septic syndrome with multiple organ failure in burnt patients: 2 cases with review of the literature. Rev Neurol (Paris) 1994;150:149-154.
51. de Seze M, Petit H, Wiart L, Cardinaud JP, Gaujard E, Joseph PA, et al. Crilical illness polyneuropathy. A 2-year follow-up study in 19 severe cases. Eur Neurol 2000;43:61-69.
52. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-873.
53. Dhainaut JF, Tenaillon A, Le Tulzo Y, Schlemmer B, Solet JP, Wolff M, el al. Platelet-activaling factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Crit Care Med 1994;22:1720-1728.
54. Di Giovanni S, Molon A, Broccolini A, Melcon G, Mirabella M, Hoffman EP, et al. Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 2004;55:195-206.
55. Dimachkie MM, Austin SG, Slopis JM, Vriesendorp FJ. Critical illness polyneuropathy in adolescence. J Child Neurol 1995;10:409-411.
56. Douglass JA, Tuxen DV, Horne M, Scheinkestel CD, Weinmann M, Czarny D, et al. Myopathy in severe asthma. Am Rev Respir Dis 1992;146:517-519.
57. Druschky A, Herkert M, Radespiel-Troger M, Druschky K, Hund E, Becker CM, et al. Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 2001;27:686-693.
58. Dussoix P, Chevrolet JC, Cox J, Pizzolato G, Magistris MR. Neuromyopathies secondaires en reanimation. Reanim Urg 1993;2:247.
59. Erbsloh F. Polyneuritic pathological conditions in internal medicine. Munch Med Wochenschr 1955;97:753-756.
60. Faragher MW, Day BJ, Dennett X. Critical care myopathy: an electrophysiological and histological study. Muscle Nerve 1996;19:516-518.
61. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001;345:408-416.
62. Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126.
63. Fenzi F, Latronico N, Refatti N, Rizzuto N. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol (Berl) 2003;106:75-82.
64. Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003;31:1012-1016.
65. Fong Y, Moldawer LL, Marano M, Wei H, Barber A, Manogue K, et al. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol 1989;256:R659-R665.
66. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001;27:1288-1296.
67. Geller TJ, Kaiboriboon K, Fenton GA, Hayat GR. Vecuronium-associated axonal motor neuropathy: a variant of critical illness polyneuropathy? Neuromuscul Disord 2001;11:579-582.
68. Giostra E, Magistris MR, Pizzolato G, Cox J, Chevrolet JC. Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Occurrence in a cluster group of seven patients and two sporadic cases, with electrophysiologic and histologic examination. Chest 1994;106:210-220.
69. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: pathogenesis. Lancet 1991;338:732-736.
70. Gooch JL. Prolonged paralysis after neuromuscular blockade. J Toxicol Clin Toxicol 1995;33:419-426.
71. Gooch JL, Suchyta MR, Balbierz JM, Petajan JH, Clemmer TP. Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991;19:1125-1131.
72. Gorson KC, Ropper AH. Acute respiratory failure neuropathy: a variant of critical illness polyneuropathy. Crit Care Med 1993;21:267-271.
73. Grand'Maison F. Methods of testing neuromuscular transmission in the intensive care unit. Can J Neurol Sci 1998;25: S36-S39.
74. Hanson P, Dive A, Brucher JM, Bisteau M, Dangoisse M, Deltombe T. Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 1997;20:137l-1380.
75. Helliwell TR, Coakley JH, Wagenmakers AJ, Griffiths RD, Campbell IT, Green CJ, et al. Necrotizing myopathy in critically-ill patients. J Pathol 1991;164:307-314.
76. Helm PA, Johnson ER, Carlton AM. Peripheral neurological problems in the acute burn patient. Burns 1977;3:123-125.
77. Henderson B, Koepke GH, Feller I. Peripheral polyneuropathy among patients with burns. Arch Phys Med Rehabil 1971;52:149-151.
78. Hirano M, Ott BR, Raps EC, Minetti C, Lennihan L, Libbey NP, et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992;42:2082-2087.
79. Hoke A, Rewcastle NB, Zochodne DW. Acute quadriplegic myopathy unrelated to steroids or paralyzing agents: quantitative EMG studies. Can J Neurol Sci 1999;26:325-329.
80. Hsia AW, Hattab EM, Katz JS. Malnutrition-induced myopathy following Roux-en-Y gastric bypass. Muscle Nerve 2001;24:1692-1694.
81. Hoch W, McConville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MUSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-368.
82. Hund E. Myopathy in critically ill patients. Crit Care Med 1999;27:2544-2547.
83. Hund E. Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 2001;248:929-934.
84. Hund EF, Fogel W, Krieger D, DeGeorgia M, Hacke W. Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med 1996;24:1328-1333.
85. Jackson AC, Gilbert JJ, Young GB, Bolton CF. The encephalopathy of sepsis. Can J Neurol Sci 1985;12:303-307.
86. Ji S, Sun W, George AL Jr, Horn R, Barchi RL. Voltage-dependent regulation of modal gating in the rat SkM1 sodium channel expressed in Xenopus oocytes. J Gen Physiol 1994;104:625-643.
87. Karpati G, Carpenter S, Eisen AA. Experimental core-like lesions and nemaline rods. A correlative morphological and physiological study. Arch Neurol 1972;27:237-251.
88. Kelly BJ, Matthay MA. Prevalence and severity of neurologic dysfunction in critically ill patients. Influence on need for continued mechanical ventilation. Chest 1993;104:1818-1824.
89. Kupfer Y, Namba T, Kaldawi E, Tessler S. Prolonged weakness after long-term infusion of vecuronium bromide. Ann Intern Med 1992;117:484-486.
90. Lacomis D. Critical illness myopathy. Curr Rheumatol Rep 2002;4:403-408.
91. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996;40:645-654.
92. Lacomis D, Petrella JT, Giuliani MJ. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 1998;21:610-617.
93. Lacomis D, Smith TW, Chad DA. Acute myopathy and neuropathy in status asthmaticus: case report and literature review. Muscle Nerve 1993;16:84-90.
94. Lacomis D, Zochodne DW, Bird SJ. Critical illness myopathy. Muscle Nerve 2000;23:1785-1788.
95. Lange DJ. Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve 1994;17:16-30.
96. Lannigan R, Austin TW, Vestrup J. Myositis and rhabdomyolysis due to Staphylococcus aureus septicemia. J Infect Dis 1984;150:784.
97. Larsson L, Li X, Edstrom L, Eriksson LI, Zackrisson H, Argentini C, et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med 2000;28:34-45.
98. Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, et al. Critical illness myopathy and neuropathy. Lancet 1996;347:1579-1582.
99. Leijten FS. Critical illness polyneuropathy - a longitudinal study. Leiden: Rijksuniversiteit te Leiden; 1996.
100. Leijten FS, de Weerd AW. Critical illness polyneuropathy. A review of the literature, definition and pathophysiology. Clin Neurol Neurosurg 1994;96:10-19.
101. Leijten FS, de Weerd AW. Letter to the Editor. N Engl J Med 1990;323:1631.
102. Leijten FS, De Weerd AW, Poortvliet DC, De Ridder VA, Ulrich C, Harink-De Weerd JE. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 1996;22:856-861.
103. Leijten FS, Harinck-De Weerd JE, Poortvliet DC, de Weerd AW. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995;274:1221-1225.
104. Lemaire F. Difficult weaning. Intensive Care Med 1993;19: S69-S73.
105. Levy H, Ash SR, Knab W, Steczko J, Carr DJ, Blake DE. Systemic inflammatory response syndrome treatment by powdered sorbent pheresis: the BioLogic-Detoxification Plasma Filtration System. Asaio J 1998;44:M659-M665.
106. Low PA, Nickander KK, Seionti L. Role of hypoxia, oxidative stress, and excitatory neurotoxins in diabetic neuropathy. In: Dyck PJ, Thomas PK, editors. Diabetic neuropathy, 2nd ed. Philadelphia: WB Saunders; 1999. p 317-329.
107. Low PA, Tuck RR, Takeuchi M. Nerve microenvironment in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, editors. Diabetic neuropathy. Philadelphia: WB Saunders; 1987. p 268-277.
108. Lowry SF. Sepsis and its complications: clinical definitions and therapeutic prospects. Crit Care Med 1994;22:S1-S2.
109. Lycklama J, Nijeholt A, Troost J. Critical illness polyneuropathy. In: Matthews WB, editor. Handbook of clinical neurology. New York: Elsevier Science; 1987. p 129-135.
110. MacFarlene IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet 1977;ii:615.
111. Magistris MR. Critical illness neuropathies. Rev Neurol (Paris) 2002;158:293-299.
112. Maher J, Grand'Maison F, Nicolle MW, Strong MJ, Bolton CF. Diagnostic difficulties in myasthenia gravis. Muscle Nerve 1998;21:577-583.
113. Mäher J, Rutledge F, Remtulla H, Parkes A, Bernardi L, Bolton CF. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 1995;21:737-743.
114. Marino PL, Millili JJ. Possible role of dietary lipids in critical illness polyneuropathy. Intensive Care Med 1998;24:87.
115. Marquez S, Turley JJ, Peters WJ. Neuropathy in burn patients. Brain 1993;116:471-483.
116. Massa R, Carpenter S, Holland P, Karpati G. Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 1992;15:1290-1298.
117. McLoughlin DM, Spargo E, Wassif WS, Newham DJ, Peters TJ, Lantos PL, et al. Structural and functional changes in skeletal muscle in anorexia nervosa. Acta Neuropathol (Berl) 1998;95:632-640.
118. Mertens HG. Disseminated neuropathy following coma. On the differentation of so-called toxic polyneuropathy. Nervenarzt 1961;32:71-79.
119. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 2004;89:219-226.
120. Milner-Brown HS, Miller RG. Muscle membrane excitation and impulse propagation velocity are reduced during muscle fatigue. Muscle Nerve 1986;9:367-374.
121. Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 1997;23:1144-1149.
122. Nicolle MW, Stewart DJ, Remtulla H, Chen R, Bolton CF. Lambert-Eaton myasthenic syndrome presenting with severe respiratory failure. Muscle Nerve 1996;19:1328-1333.
123. Op de Coul AA, Lambregts PC, Koeman J, van Puyenbroek MJ, Ter Laak HJ, Gabreels-Festen AA. Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 1985;87:17-22.
124. Op de Coul AA, Verheul GA, Leyten AC, Schellens RL, Teepen JL. Critical illness polyneuromyopathy after artificial respiration. Clin Neurol Neurosurg 1991;93:27-33.
125. Opal SM, Yu RL Jr. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions. Drugs 1998;55:497-508.
126. Osler W. The principles and practice of medicine. New York: D Appleton; 1892.
127. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
128. Pappone PA. Voltage-clamp experiments in normal and denervated mammalian skeletal muscle fibres. J Physiol 1980;306:377-410.
129. Partridge BL, Abrams JH, Bazemore C, Rubin R. Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 1990;18:1177-1179.
130. Penn AS. Myoglobulinuria. In: Engel AG, Banker BQ, editors. Myology. New York: McGraw-Hill; 1994; p 1679-1696.
131. Perea M, Picon M, Miro O, OrusJ, Roig E, Grau JM. Acute quadriplegic myopathy with loss of thick (myosin) filaments following heart transplantation. J Heart Lung Transplant 2001;20:1136-1141.
132. Petersen B, Schneider C, Strassburg HM, Schrod L. Critical illness neuropathy in pediatric intensive care patients. Pediatr Neurol 1999;21:749-753.
133. Ramsay DA, Zochodne DW, Robertson DM, Nag S, Ludwin SK. A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 1993;52:387-398.
134. Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997;20:665-673.
135. Rich MM, Kraner SD, Barchi RL. Altered gene expression in steroid-treated denervated muscle. Neurobiol Dis 1999;6:515-522.
136. Rich MM, McGarvey ML, Teener JW, Frame LH. ECG changes during septic shock. Cardiology 2002;97:187-196.
137. Rich MM, Pinter MJ. Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 2001;50:26-33.
138. Rich MM, Pinter MJ, Kraner SD, Barchi RL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 1998;43:171-179.
139. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996;46:731-736.
140. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest 2003;112:460-467.
141. Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med 2003;9:517-524.
142. Rivner MH, Kim S, Greenberg M, Swift TR. Reversible generalized paresis following hypotension: a new neurological entity. Neurology 1983;33:164-165.
143. Roelofs RI, Cerra F, Bielka N, et al. Prolonged respiratory insufficiency due to acute motor neuropathy: a new syndrome. Neurology 1983;33:240.
144. Ropper AH, Wijdicks EF, Truax BT. Guillain-Barré syndrome. Philadelphia: FA Davis; 1991. 369 p.
145. Rossiter A, Souney PF, McGowan S, Carvajal P. Pancuronium-induced prolonged neuromuscular blockade. Crit Care Med 1991;19:1583-1587.
146. Rouleau G, Karpati G, Carpenter S, Soza M, Prescott S, Holland P. Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve 1987;10:428-438.
147. Sander HW, Golden M, Danon MJ. Quadriplegic areflexic ICU illness: selective thick filament loss and normal nerve histology. Muscle Nerve 2002;26:499-505.
148. Sander HW, Saadeh PB, Chandswang N, Greenbaum D, Chokroverty S. Diaphragmatic denervation in intensive care unit patients. Electromyogr Clin Neurophysiol 1999;39:3-5.
149. Satran R, Almog Y. The coagulopathy of sepsis: pathophysiology and management. Isr Med Assoc J 2003;5:516-520.
150. Schwarz J, Planck J, Briegel J, Straube A. Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons. Muscle Nerve 1997;20:696-701.
151. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992;327:524-528.
152. Sher JH, Shafiq SA, Schutta HS. Acute myopathy with selective lysis of myosin filaments. Neurology 1979;29:100-106.
153. Sheth RD, Bolton CF. Neuromuscular complications of sepsis in children. J Child Neurol 1995;10:346-352.
154. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997;20:316-322.
155. Singh U, Scheid WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis 1996;22:642-649.
156. Sitwell LD, Weinshenker BG, Monpetit V, Reid D. Complete ophthalmoplegia as a complication of acute conicosteroid- and pancuronium-associated myopathy. Neurology 1991;41:921-922.
157. Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, et al. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit Care Med 1994;22:1738-1746.
158. Spitzer AR, Giancarlo T, Maher L, Awerbuch G, Bowles A. Neuromuscular causes of prolonged ventilator dependency. Muscle Nerve 1992;15:682-686.
159. Subramony SH, Carpenter DE, Raju S, Pride M, Evans OB. Myopathy and prolonged neuromuscular blockade after lung transplant. Crit Care Med 1991;19:1580-1582.
160. Tan MJ, Kandier R, Baxter PS. Focal neuropathy in children with critical illness. Neuropediatrics 2003;34:149-151.
161. Teitelbaum J, Zatorre RJ, Carpenter S, Gendron D, Cashman NR. Neurological sequelae of domoic acid intoxication. Can Dis Wkly Rep 1990;16:9-12.
162. Tenckhoff HA, Boen ST, Jebsen RH, Spiegler JH. Polyneuropathy in chronic renal insufficiency. JAMA 1965;192:1121-1124.
163. Tennila A, Salmi T, Pettila V, Roine RO, Varpula T, Takkunen O. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 2000;26:1360-1363.
164. Tracey KJ, Lowry SF, Beutler B, et al. Cachectin/tumor necrosis factor mediates human muscle denervation: topical 31-P spectroscopy studies. Magn Reson Med 1988;7:373-383.
165. Tran DD, Groeneyeld AB, van der Meulen J, Nauta JJ, Strack van Schijndel RJ, Thijs LG. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 1990;18:474-479.
166. Trojaborg W, Weimer LH, Hays AP. Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy - a reappraisal. Clin Neurophysiol 2001;112:1586-1593.
167. Tsao CY, Lo WD, Mendell JR, Badey RJ. Critical illness polyneuropathy in a 2-year-old girl with hemorrhagic shock encephalopathy syndrome. J Child Neurol 1995;10:486-488.
168. van den Berghe G, Wouters P, Weckers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
169. van der Schaaf M, Beelen A, de Groot IJ. Critical illness polyneuropathy: a summary of the literature on rehabilitation outcome. Disabil Rehabil 2000;22:808-810.
170. van Mook WN, Hulsewe-Evers RP. Critical illness polyneuropathy. Curr Opin Crit Care 2002;8:302-310.
171. Waldhausen E, Keser G, Schulz WB, Lippers P. Weaning failure due to acute neuromuscular disease. Crit Care Med 1989;17:594-595.
172. Waldhausen E, Mingers B, Lippers P, Keser G. Critical illness polyneuropathy due to parenteral nutrition. Intensive Care Med 1997;23:922-923.
173. Wernig A, Pecot-Dechavassine M, Stover H. Sprouting and regression of the nerve at the frog neuromuscular junction in normal conditions and after prolonged paralysis with curare. J Neurocytol 1980;9:278-303.
174. Wijdicks EF. Neurology of critical illness. Philadelphia: FA Davis; 1994. 360 p.
175. Wijdicks EF, Fulgham JR. Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy. Muscle Nerve 1994;17:1494-1495.
176. Wijdicks EF, Litchy WJ, Harrison BA, Gracey DR. The clinical spectrum of critical illness polyneuropathy. Mayo Clin Proc 1994;69:955-959.
177. Wilbourn AJ. Peripheral neuropathies associated with vascular diseases and the vasculitides. In: Brown WF, Bolton CF, Aminoff MJ, editors. Neuromuscular function and disease. Philadelphia: WB Saunders; 2002. p 1229-1249.
178. Wilbourn AJ, Furlan AJ, Hulley W, Ruschhaupt W. Ischemic monomelic neuropathy. Neurology 1983;33:447-451.
179. Wilmshurst PT, Treacher DF, Lantos PL, Wiles CM. Critical illness poly-neuropathy following severe hyperpyrexia. QJM 1995;88:351-355.
180. Wilson JX, Young GB. Progress in clinical neurosciences: sepsis-associated encephalopathy. evolving concepts. Can J Neurol Sci 2003;30:98-105.
181. Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F, Wells G, Young GB, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991;99:176-184.
182. Wokke JH, Jennekens FG, van den Oord CJ, Veldman H, van Gijn J. Histological investigations of muscle atrophy and end plates in two critically ill patients with generalized weakness. J Neurol Sci 1988;88:95-106.
183. Young GB, Bolton CF, Archibald YM, Austin TW, Wells GA. The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol 1992;9:145-152.
184. Young GB, Bolton CF, Austin TW, Archibald YM, Gonder J, Wells GA. The encephalopathy associated with septic illness. Clin Invest Med 1990;13:297-304.
185. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996;49:314-326.
186. Zhang Y, Hartmann HA, Satin J. Glycosylation influences voltage-dependent gating of cardiac and skeletal muscle sodium channels. J Membr Biol 1999;171:195-207.
187. Zifko U, Chen R, Remtulla H, Hahn AF, Koopman W, Bolton CF. Respiratory electrophysiological studies in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1996;60:191-194.
188. Zifko UA. Electrophysiological respiratory studies in the critical care unit. Can J Neurol Sci 1998;25:S21-S26.
189. Zifko UA. Long-term outcome of critical illness polyneuropathy. Muscle Nerve 2000;9(Suppl):S49-S52.
190. Zifko UA, Zipko HT, Bolton CF. Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 1998;159:186-193.
191. Zochodne DW, Bolton CF. Neuromuscular disorders in critical illness. Baillieres Clin Neurol 1996;5:645-671.
192. Zochodne DW, Bolton CF, Laverty DA, Thompson RT, Driedger AA. The effects of sepsis and muscle function: an electrophysiologic and P-31 NMR study. Electroencephalogr Clin Neurophysiol 1987;66:S115-S1165.
193. Zochodne DW, Bolton CF, Thompson RT, Driedger AA, Hahn AF, Gilbert JJ. Myopathy in critical illness. Muscle Nerve 1986;9:652.
194. Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987;110:819-841.
195. Zochodne DW, Ramsay DA, Saly V, Shelley S, Moffatt S. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994;17:285-292.
196. Zochodne DW, Thompson RT, Driedger AA, Strong MJ, Gravelle D, Bolton CF. Metabolic changes in human muscle denervation: topical 31P NMR spectroscopy studies. Magn Reson Med 1988;7:373-383.